Video capsule endoscopy for obscure GI bleeding and Crohn's disease (Update of Report 7)
Xie X, McGregor M
Record ID 32012000902
English
Authors' recommendations:
• The present evidence is consistent that for the diagnosis of patients with small bowel disease VCE provides a
comparable and sometimes higher diagnostic yield than alternative diagnostic approaches.
• For patients with OGIB, the diagnostic yield of VCE is significantly higher than that of push enteroscopy, and small
bowel barium radiography, and not significantly different from that of double balloon enteroscopy.
• For patients with suspected and established small-bowel Crohn's Disease, the diagnostic yield of VCE is
significantly higher than that of small bowel barium radiography, CT enterography/enteroclysis, colonoscopy with
ileoscopy and push enteroscopy. There is no statistically significant difference in yield between VCE and MRE
enterography.
• In spite of the absence of data it must be noted that VCE may be associated with overdiagnosis. Two RCTs have
demonstrated that compared with other diagnostic tests, VCE did not significantly improve the clinical outcomes in
1 year follow-up.
• While the optimal sequence of diagnostic tests must be determined for each case, there is agreement that VCE
should not be a first line test.
• The unit cost to the MUHC of each VCE study is estimated to be $984.55. The budget impact of the projected 100
tests per year would therefore be $98,455. Its use will reduce demand on alternative test procedures, thus
diminishing wait times.
Details
Project Status:
Completed
Year Published:
2012
URL for published report:
http://www.mcgill.ca/tau/files/tau/muhc_tau_2012_60_vce.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Gastrointestinal Hemorrhage
- Crohn Disease
Contact
Organisation Name:
Technology Assessment Unit of the McGill University Health Centre (MUHC)
Contact Address:
Technology Assessment Unit of the MUHC, Centre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, 5252 boul. de Maisonneuve, Bureau 3F.50, Montreal, Quebec H4A 3S5
Contact Name:
nandini.dendukuri@mcgill.ca
Contact Email:
nandini.dendukuri@mcgill.ca
Copyright:
Technology Assessment Unit of the McGill University Health Centre (MUHC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.